LD-2 disclosure · 4th Quarter - Report
ATEA PHARMACEUTICALS
Client
- Description
- Biotechnology company focused on antiviral therapeutics.
- Location
- Maryland · United States of America
Registrant
- Description
- Government Relations Firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
2 issuesHealth Issues
Support and funding for COVID-19 therapeutics.
LobbyistsBRIAN SUTTER · EMILY ELIZABETH WILKINSON-HOLLAND · mr CHRISTOPHER DAVIS
Covered position (BRIAN SUTTER): Staff Dir. W&M Health subcommittee, Chairman Dave Camp April'13-Dec'14. Professional Staff, W&M Health subcommittee, Chairman Dave Camp, Jan'11-April'13. Leg Dir. Rep Dave Camp, May'08-Jan'11. Leg Asst Rep Dave Camp, Feb'03-May'08. Staff Ast July'02
Covered position (EMILY ELIZABETH WILKINSON-HOLLAND): Staff -Rep. Price (2010-11), LA: Rep. Grimm (2011-12), Rep. Black (2012-13), Sen.Vitter (2013-2015), Sen. Heller (2015-17), Policy Adv. to the Sec.- Dept of HHS (3/2017-8/2017), Sr Advisor to Administrator - Ctrs for Medicare & Medicaid (8/17- 5/19).
Covered position (mr CHRISTOPHER DAVIS): Staff Assistant, Legislative Assistant, Senior Legislative Assistant, and Legislative Director - Rep. Rick Boucher (2006-2011)
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medical/Disease Research/Clinical Labs
Support and funding for COVID-19 therapeutics. Issues related to the Pandemic and All Hazards Preparedness Act (PAHPA).
LobbyistsBRIAN SUTTER · EMILY ELIZABETH WILKINSON-HOLLAND · mr CHRISTOPHER DAVIS
Covered position (BRIAN SUTTER): Staff Dir. W&M Health subcommittee, Chairman Dave Camp April'13-Dec'14. Professional Staff, W&M Health subcommittee, Chairman Dave Camp, Jan'11-April'13. Leg Dir. Rep Dave Camp, May'08-Jan'11. Leg Asst Rep Dave Camp, Feb'03-May'08. Staff Ast July'02